DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cabergoline (Cabergoline) - Psychiatric Symptom - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Psychiatric Symptom (6)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cabergoline where reactions include psychiatric symptom. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Cabergoline side effects in 53 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-19

Patient: 53 year old male

Reactions: Blepharospasm, Psychiatric Symptom, Atrioventricular Block Complete

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Alprazolam
    Dosage: 0.4 mg, 2 in 1 d
    Administration route: Oral
    Indication: Anxiety Disorder

Cabergoline
    Dosage: 1 mg, 1 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease
    End date: 2012-06-19

Carbidopa
    Dosage: 87.5 mg, 6 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2011-07-20

Comtan
    Dosage: 100 mg, 1 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease

Donepezil HCL
    Dosage: 5 mg, 1 in 1 d
    Administration route: Oral
    Start date: 2011-07-05
    End date: 2012-06-21

Donepezil HCL
    Dosage: blinded therapy (3mg or placebo) (1 in 1 d)
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2011-06-23
    End date: 2011-07-04

Pramipexole Dihydrochloride
    Dosage: 1 mg, 2 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease

Pramipexole Dihydrochloride
    Dosage: 0.25 mg, 1 in 1 d
    Administration route: Oral
    Start date: 2012-01-18

Seroquel
    Dosage: 25 mg, 1 in 1 d
    Administration route: Oral
    Indication: Psychiatric Symptom
    Start date: 2012-06-21
    End date: 2012-06-23

Symmetrel
    Dosage: 50 mg, 4 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease
    End date: 2012-06-19

Zyprexa
    Dosage: 5 mg, 1 in 1 d
    Administration route: Oral
    Indication: Psychiatric Symptom
    Start date: 2012-06-23

Other drugs received by patient: Rinderon-V



Possible Cabergoline side effects in 53 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-13

Patient: 53 year old male

Reactions: Blepharospasm, Psychiatric Symptom, Atrioventricular Block Complete

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Alprazolam
    Dosage: 0.4 mg, 2 in 1 d
    Administration route: Oral
    Indication: Anxiety Disorder

Cabergoline
    Dosage: 1 mg, 1 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease
    End date: 2012-06-19

Comtan
    Dosage: 100 mg, 1 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease

Donepezil HCL
    Dosage: 5 mg, 1 in 1 d
    Administration route: Oral
    Start date: 2011-07-05
    End date: 2012-06-21

Donepezil HCL
    Dosage: blinded therapy (3mg or placebo) (1 in 1 d)
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2011-06-23
    End date: 2011-07-04

Dopacol
    Dosage: 87.5 mg, 6 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2011-07-20

Pramipexole Dihydrochloride
    Dosage: 0.25 mg, 1 in 1 d
    Administration route: Oral
    Start date: 2012-01-18

Pramipexole Dihydrochloride
    Dosage: 1 mg, 2 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease

Seroquel
    Dosage: 25 mg, 1 in 1 d
    Administration route: Oral
    Indication: Psychiatric Symptom
    Start date: 2012-06-21
    End date: 2012-06-23

Symmetrel
    Dosage: 50 mg, 4 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease
    End date: 2012-06-19

Zyprexa
    Dosage: 5 mg, 1 in 1 d
    Administration route: Oral
    Indication: Psychiatric Symptom
    Start date: 2012-06-23

Other drugs received by patient: Rinderon-V



Possible Cabergoline side effects in 53 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-11

Patient: 53 year old male

Reactions: Blepharospasm, Atrioventricular Block Complete, Psychiatric Symptom

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cabergoline
    Dosage: 1 mg, 1 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease
    End date: 2012-06-19

Comtan
    Dosage: 100 mg, 1 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease

Donepezil HCL
    Dosage: blinded therapy (3mg or placebo) (1 in 1 d)
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2011-06-23
    End date: 2011-07-04

Donepezil HCL
    Dosage: 5 mg, 1 in 1 d
    Administration route: Oral
    Start date: 2011-07-05
    End date: 2012-06-21

Dopacol
    Dosage: 87.5 mg, 6 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2011-07-20

Pramipexole Dihydrochloride
    Dosage: 0.25 mg, 1 in 1 d
    Administration route: Oral
    Start date: 2012-01-18

Pramipexole Dihydrochloride
    Dosage: 1 mg, 2 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease

Seroquel
    Dosage: 25 mg, 1 in 1 d
    Administration route: Oral
    Indication: Psychiatric Symptom
    Start date: 2012-06-21
    End date: 2012-06-23

Symmetrel
    Dosage: 50 mg, 4 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease
    End date: 2012-06-19

Zyprexa
    Dosage: 5 mg, 1 in 1 d
    Administration route: Oral
    Indication: Psychiatric Symptom
    Start date: 2012-06-23

Other drugs received by patient: Alprazolam; Rinderon-V



Possible Cabergoline side effects in 53 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-10

Patient: 53 year old male

Reactions: Blepharospasm, Atrioventricular Block Complete, Psychiatric Symptom

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cabergoline
    Dosage: 1 mg, 1 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease
    End date: 2012-06-19

Carbidopa + Levodopa
    Dosage: 87.5 mg, 6 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2011-07-20

Comtan
    Dosage: 100 mg, 1 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease

Donepezil HCL
    Dosage: blinded therapy (3mg or placebo) (1 in 1 d)
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2011-06-23
    End date: 2011-07-04

Donepezil HCL
    Dosage: 5 mg, 1 in 1 d
    Administration route: Oral
    Start date: 2011-07-05
    End date: 2012-06-21

Pramipexole Dihydrochloride
    Dosage: 0.25 mg, 1 in 1 d
    Administration route: Oral
    Start date: 2012-01-18

Pramipexole Dihydrochloride
    Dosage: 1 mg, 2 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease

Seroquel
    Dosage: 25 mg, 1 in 1 d
    Administration route: Oral
    Indication: Psychiatric Symptom
    Start date: 2012-06-21
    End date: 2012-06-23

Symmetrel
    Dosage: 50 mg, 4 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease
    End date: 2012-06-19

Zyprexa
    Dosage: 5 mg, 1 in 1 d
    Administration route: Oral
    Indication: Psychiatric Symptom
    Start date: 2012-06-23

Other drugs received by patient: Rinderon-V; Alprazolam



Possible Cabergoline side effects in 42 year old female

Reported by a physician from Japan on 2011-12-22

Patient: 42 year old female

Reactions: Psychiatric Symptom

Drug(s) suspected as cause:
Cabergoline



Possible Cabergoline side effects in

Reported by a physician from Japan on 2011-11-21

Patient:

Reactions: Psychiatric Symptom

Drug(s) suspected as cause:
Cabergoline

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017